These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626 [TBL] [Abstract][Full Text] [Related]
7. A retrospective database analysis of neuropathic pain and oral antidiabetic medication use and adherence among Texas adults with type 2 diabetes enrolled in Medicaid. Oladapo AO; Barner JC; Rascati KL; Strassels SA Clin Ther; 2012 Mar; 34(3):605-13. PubMed ID: 22386828 [TBL] [Abstract][Full Text] [Related]
9. Comorbidities, healthcare service utilization and costs for patients identified with painful DPN in a managed-care setting. Ritzwoller DP; Ellis JL; Korner EJ; Hartsfield CL; Sadosky A Curr Med Res Opin; 2009 Jun; 25(6):1319-28. PubMed ID: 19419344 [TBL] [Abstract][Full Text] [Related]
10. Painful diabetic neuropathy: treatment and future aspects. Ziegler D Diabetes Metab Res Rev; 2008; 24 Suppl 1():S52-7. PubMed ID: 18395890 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy. Barbano RL; Herrmann DN; Hart-Gouleau S; Pennella-Vaughan J; Lodewick PA; Dworkin RH Arch Neurol; 2004 Jun; 61(6):914-8. PubMed ID: 15210530 [TBL] [Abstract][Full Text] [Related]
13. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Davies M; Brophy S; Williams R; Taylor A Diabetes Care; 2006 Jul; 29(7):1518-22. PubMed ID: 16801572 [TBL] [Abstract][Full Text] [Related]
14. New and emerging treatment options for neuropathic pain. Gidal BE Am J Manag Care; 2006 Jun; 12(9 Suppl):S269-78. PubMed ID: 16774459 [TBL] [Abstract][Full Text] [Related]
15. Burden of illness in painful diabetic peripheral neuropathy: the patients' perspectives. Gore M; Brandenburg NA; Hoffman DL; Tai KS; Stacey B J Pain; 2006 Dec; 7(12):892-900. PubMed ID: 17157775 [TBL] [Abstract][Full Text] [Related]
17. [Pharmacologic therapy in peripheral diabetic polyneuropathy]. Mihai B; Lăcătuşu C; Graur M; Cijevschi-Prelipcean C; Mihai C Rev Med Chir Soc Med Nat Iasi; 2010; 114(2):332-41. PubMed ID: 20700963 [TBL] [Abstract][Full Text] [Related]
18. Advances in the management of diabetic peripheral neuropathy. Tesfaye S Curr Opin Support Palliat Care; 2009 Jun; 3(2):136-43. PubMed ID: 19421063 [TBL] [Abstract][Full Text] [Related]
19. Treatment of symptomatic diabetic neuropathy. Boulton AJ Diabetes Metab Res Rev; 2003; 19 Suppl 1():S16-21. PubMed ID: 12577254 [TBL] [Abstract][Full Text] [Related]
20. Pharmacology and treatment of neuropathic pains. Jensen TS; Madsen CS; Finnerup NB Curr Opin Neurol; 2009 Oct; 22(5):467-74. PubMed ID: 19741531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]